Rosalia Kaufman

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Yeda Research and Develpment & Co. Ltd, Kadimastem Ltd., The Weizmann Institute of Science. Active years: 2014-2022.

USPTO Granted Patents = 5 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 7(Granted Patents)

Location History:

Rehovot, IL (2016)
Rechovot, IL (2014 - 2022)

Company Filing History:

3 out of 1,168

Yeda Research and Develpment & Co. Ltd

The Weizmann Institute of Science

patents

Years Active: 2014-2022

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11406670 - Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS (2022-08-09),

2. 10258651 - Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS (2019-04-16),

3. 9631175 - Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS (2017-04-25),

4. 9404087 - Insulin producing cells derived from pluripotent stem cells (2016-08-02),

5. 8809052 - Methods of generating mature oligodendrocytes (2014-08-19),

Title: Rosalia Kaufman: Innovator in Neural and Glial Cell Generation

Introduction

Rosalia Kaufman is a prominent inventor based in Rechovot, Israel. She has made significant contributions to the field of neuroscience, particularly in the generation of glial and neuronal cells. With a total of 5 patents, her work has the potential to impact the treatment of various medical conditions affecting the central nervous system (CNS).

Latest Patents

Kaufman's latest patents focus on innovative methods for generating neural and glial cells. One of her notable patents describes a method that involves growing human stem cells under specific conditions that promote their differentiation into neural and glial cells. These conditions include the presence of retinoic acid and an agent that down-regulates Bone Morphogenic Protein activity. This groundbreaking approach could pave the way for new treatments for CNS-related medical conditions.

Career Highlights

Throughout her career, Kaufman has worked with esteemed organizations such as Yeda Research and Development Co. Ltd. and Kadimastem Ltd. Her research has garnered attention for its potential applications in regenerative medicine and therapeutic interventions.

Collaborations

Kaufman has collaborated with notable colleagues, including Michel Revel and Judith Chebath, who have contributed to her research endeavors. Their combined expertise has further advanced the understanding of neural and glial cell generation.

Conclusion

Rosalia Kaufman's innovative work in the field of neuroscience exemplifies the impact of her research on medical science. Her patents and collaborations highlight her commitment to advancing treatments for CNS conditions. The significance of her contributions continues to resonate within the scientific community.